Principal Investigator
Gilberto Lopes
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240477
Clinical Trial Summary
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M07D1 in Subjects With HER2 Expressing Advanced Malignant Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647